Navigation Links
ViroPharma to Release 2009 Third Quarter Financial Results on October 28, 2009
Date:10/15/2009

EXTON, Pa., Oct. 15 /PRNewswire-FirstCall/ -- ViroPharma Incorporated's (Nasdaq: VPHM) third quarter financial results for 2009 are expected to be released on Wednesday, October 28, 2009 before the open of the U.S. financial markets.

The company will host a conference call and live audio webcast at 9:00 a.m. Eastern Time on the same day. During the conference call, ViroPharma management will discuss the 2009 third quarter and other business.

The press release and the live webcast of the conference call will be accessible via ViroPharma's corporate website at http://www.viropharma.com. An audio archive will be available at the same address until November 21, 2009. To participate in the conference call, please dial (888) 299-4099 (domestic) and (302) 709-8337 (international). After placing the call, please tell the operator you wish to join the ViroPharma investor conference call.

About ViroPharma Incorporated

ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin®, approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains. ViroPharma commercializes Cinryze(TM) (C1 esterase inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's commercial products, please download the package inserts at

SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program
2. ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride
3. ViroPharma Incorporated Reports Second Quarter 2009 Financial Results
4. ViroPharma to Release 2009 Second Quarter Financial Results on July 29, 2009
5. ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
6. ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products
7. ViroPharma to Present at Two May Healthcare Conferences
8. ViroPharma to Present at the Cowen & Company 29th Annual Healthcare Conference
9. ViroPharma to Host Investor Teach-In Educational Symposium on Hereditary Angioedema
10. ViroPharma to Release 2008 Fourth Quarter and Full Year Financial Results on February 24, 2009
11. ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... Since 1996, crop plants genetically modified to ...in insects, yet safe for people, have been planted...popularity of these Bt crops, named after the bact...bility to kill some major pests, allowing farmers ...reducing insecticide sprays. , However, since in...
(Date:11/23/2009)...Study found one more than doubled chances, while b... Nov. 23 (HealthDay News) -- Children whose mother...ead have more than double the risk of having atten...r children, new research shows. , And with expo...aving ADHD soared. Children whose mothers smoked d...
(Date:11/23/2009)...,, DALLAS,Nov.23/PRNewswire/--TheBerylCompani...rservicesforthehealthcareindustry,hasearnedrecogni...dernHealthcare ,theindustry,sleadingtrademagazine....gfirmsbasedonBeryl,s2008businessresults,whichenabl..., Berylattributesthisgrowthtoitsinnovativeproduct...
(Date:11/23/2009)... Information about Oxycod... launched DopeStats.com. The new site is a statist... use rates of Oxycodone in each county in the Unit...e who have used the drug for recreational or medic...FL (PRWEB) November 23, 2009 -- Legal and illegal ...
(Date:11/23/2009)... Summary: People are hire...onalities. Personality assessments give insight in...ormance. The Candidate Potential Report assesses a...summarizes the recommendation for job fit and pote...ybrook, CT (PRWEB) November 23, 2009 -- When does ...
Breaking Medicine News(10 mins):Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 2Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 3Health News:The Beryl Companies Named One of the 'Top 10 Outsourcing Firms' in Healthcare 2Health News:DopeStats.com Provides Statistics on Oxycodone Abused in Non-Medical Purposes 2Health News:Candidate Potential Report Reduces Risk of Bad Hires 2Health News:Candidate Potential Report Reduces Risk of Bad Hires 3
...lly Residents to Eat Right, Move More and Milk ...ho, May 29 The last decade can be defined by,the ... to go in and out of,fashion like shoulder pads an..., A new campaign crossing the country, the Campai...
...armaceutical Industries,Ltd. (Reuters: SUN.BO, Blo...y sent a letter to Barrie Levitt, M.D., Chairman o...Sheets: TAROF) regarding Taro,s purported,terminat...he merger as per our agreement. We remain,skeptica...
...08 - Children who can read and have good phonetic ...ounds within words may still be poor spellers. In..., Elizabeth Eglinton and Marian Annett, at the Sch...year study was carried out in a cohort of children...
...umers about Urinary Health, CROMWELL, Conn., May ...nary tract infections (UTIs) are the second most c...or more than 8 million doctor visits,each year. On...omen do not realize the signs of a UTI in the firs...
...n Up To Three Times as Many Calories as,Hand-Held,... the Nintendo Wii, are quickly becoming the most c...ainment value, these systems appear to,be helpful ...ACSM)., One of the studies presented today examin...
...ain Stable or Improve in 83% of Patients ...y 29 /PRNewswire-FirstCall/ - Novadaq(R) Technolog...cal imaging and image guidance,systems for the ope...d with the OPTTX(R) System in commercial practice ...
Other Medicine News:Health News:Message to Idaho Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Idaho Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 2Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 3Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 4Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 5Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 6Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 7Health News:AZO Answers the Burning Question: What's Up Down There? 2Health News:AZO Answers the Burning Question: What's Up Down There? 3Health News:AZO Answers the Burning Question: What's Up Down There? 4Health News:Kids' Energy Expenditure High in Active Video Games 2Health News:Novadaq Updates on OPTTX Data Reported at Euroretina 2Health News:Novadaq Updates on OPTTX Data Reported at Euroretina 3Health News:Novadaq Updates on OPTTX Data Reported at Euroretina 4
(Date:11/20/2009)...ON, Nov. 20 The United States Cour...ier District Court ruling yesterday, approving a s...ice (AWP) pharmaceutical litigation against AstraZ.../www.newscom.com/cgi-bin/prnh/20080317/AQM144LOGO ...ed consumers who purchased the pharmaceutical gian...
(Date:11/20/2009)...RK, Nov. 20 Medco Health...ng to a transformation in American healthcare thro...lready delivering higher quality clinical care and...making medicine smarter for the benefit of patient...ned how the elements in its strategy enable "Smart...
(Date:11/20/2009)...W YORK, Nov. 20 ,, Reportlinke...is available in its catalogue. ,, India Medica... ,, http://www.reportlinker.com/p0164658/Indi...to-2015.html#utm_source=prnewswire&utm_medium=...n ,, India Medical Equipment Market Analysis a...
Breaking Medicine Technology:U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 2Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 3Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 4Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 5Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 2Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 3Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 4Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 5Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 6Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 7Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 8Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 9Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 10Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 11Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 12Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 13Novavax and the NIH Agree to Evaluate a Virus like Particle 28VLP 29 Vaccine Candidate Against the Novel Influenza A 28H1N1 29 Virus 12465 1Novavax and the NIH Agree to Evaluate a Virus like Particle 28VLP 29 Vaccine Candidate Against the Novel Influenza A 28H1N1 29 Virus 12465 2Novavax and the NIH Agree to Evaluate a Virus like Particle 28VLP 29 Vaccine Candidate Against the Novel Influenza A 28H1N1 29 Virus 12465 3Novavax and the NIH Agree to Evaluate a Virus like Particle 28VLP 29 Vaccine Candidate Against the Novel Influenza A 28H1N1 29 Virus 12465 4Recovery Audit Contractor Connolly Healthcare Licenses Milliman Care Guidelines 28R 29 47886 1Recovery Audit Contractor Connolly Healthcare Licenses Milliman Care Guidelines 28R 29 47886 2Recovery Audit Contractor Connolly Healthcare Licenses Milliman Care Guidelines 28R 29 47886 3Isis Pharmaceuticals to Present at Goldman Sachs 30th Annual Global Healthcare Conference 47884 1
...search, Inc. issues a,review on Nventa Biopharmace...romising Therapeutic and Vaccine Candidate for the...mavirus (HPV)." The analyst research is,available ...com ., About Nventa Corporation:, Nventa is deve...f viral,infections and cancer, with a focus on dis...
...en, Inc.,(Nasdaq: SUPG ) today announced that inv...-arm Phase 1b clinical trial of MP470, a novel, or... The trial will evaluate,MP470 in combination with...cluding carboplatin/paclitaxel, carboplatin/etopos... is expected to enroll up to 105,patients at five ...
Other Medicine Technology:Initiation of Coverage Informational Review Issued by Scimitar Equity Research 2SuperGen Reports Initiation of Multi-arm Phase 1b Trial of Novel Tyrosine Kinase Inhibitor 2SuperGen Reports Initiation of Multi-arm Phase 1b Trial of Novel Tyrosine Kinase Inhibitor 3
FF 450plus IR
... for fast and easy operation with advanced lens me...utomatically held when the lens is properly aligne...The sophisticated alignment system guides you to c...designed with a small footprint, occupying little ...
CR6-45NM Non-Mydriatic Retinal Camera
TRC-50FXC
Medicine Products: